Industry Overview

North America medical plastics market was valued at $15.2 billion in 2024 and is projected to reach $32.9 billion by 2035, growing at a CAGR of 7.3% during the forecast period (2025–2035). The medical plastics sector in North America is expanding at a steady pace, supported by increasing healthcare investments and the modernization of medical infrastructure. The rising demand for lightweight, biocompatible materials in both diagnostic and therapeutic applications is a key driver of growth. Government initiatives promoting domestic medical device manufacturing are further accelerating material consumption. Advances in polymer engineering have enabled the development of safer, more durable components, strengthening their adoption. Notably, the growing use of plastic-based elements in imaging systems and surgical tools is enhancing market momentum. With the shift in patient care toward efficiency and hygiene, demand for specialized medical plastics continues to gain traction.

Market Dynamics

Growing Demand for Advanced Drug Delivery Systems

The North America medical plastics market is witnessing increasing demand for advanced drug delivery systems, driven by the region’s robust healthcare infrastructure and an aging population. Plastics are being widely adopted in the production of catheters, syringes, and IV bags owing to their lightweight, cost-effective, and biocompatible properties. Companies such as BASF SE are providing specialty polymers designed to meet stringent regulatory and functional requirements in drug delivery applications. Rising investment in research and development is focused on improving the safety and efficiency of plastic-based devices. Supportive government initiatives that encourage healthcare innovation further reinforce this growth trend.

Surge in Minimally Invasive Surgical Procedures

The widespread adoption of minimally invasive surgical procedures across North America is driving strong demand for medical-grade plastics. These materials are vital for the production of devices such as endoscopes, tubing, and surgical instruments that require precision, strength, and sterilizability. Mitsubishi Chemical Group has introduced advanced thermoplastics that meet stringent sterilization and performance standards, aligning with these requirements. Healthcare facilities are increasingly favoring plastic components over metal alternatives due to greater cost efficiency and design flexibility. Additionally, the emphasis on reducing hospital stays and minimizing infection risks is contributing to the rising use of disposable plastic surgical instruments, highlighting the region’s commitment to safe and advanced healthcare solutions.

Market Segmentation

• Based on the plastic type, the market is segmented into traditional plastics and engineered plastics.
• Based on the application, the market is segmented into disposables, diagnostic instruments, catheters and syringes, implants, dental tools, surgical instruments, medical bags, drug delivery devices, and others.

Engineered Plastics Segment to Lead the Market with the Largest Share

Demand for engineered medical plastics in North America is steadily increasing, particularly for use in diagnostic and surgical equipment. These high-performance materials provide excellent chemical resistance, durability, and compatibility with sterilization processes. Mitsubishi Chemical Group, for example, supplies medical-grade polymers that are integral to imaging systems and fluid management components. The growing prevalence of minimally invasive procedures continues to create opportunities for precision-engineered plastics. Expansion of regional healthcare infrastructure and collaborations between polymer manufacturers and medical device companies are further advancing innovation in this segment.

Disposables: A Key Segment in Market Growth

The rising adoption of single-use medical products is significantly contributing to the growth of the North America medical plastics market. Disposable products such as syringes, catheters, and IV tubing are increasingly preferred to minimize the risk of cross-contamination. TekniPlex Healthcare, among others, provides custom plastic compounds designed for disposable medical devices. Regulatory emphasis on patient safety and infection prevention has accelerated the transition toward polymer-based consumables. In addition, expanding local manufacturing capacities are supporting sustained supply for healthcare-grade disposables, reinforcing market expansion.

Regional Outlook

The North America medical plastics market is further divided by countries, including the US and Canada.

US Dominates the Market with a Major Share

The US medical plastics market is experiencing notable growth, underpinned by rising investments in domestic healthcare manufacturing. Strategic efforts to strengthen self-reliance in medical technologies have boosted demand for high-grade polymers. Shenzhen Woer New Material, for instance, supplies specialty tubing for use in diagnostic and therapeutic applications within the US market. The country’s aging population and increasing prevalence of chronic diseases are further driving demand for polymer-based healthcare solutions. Supportive government policies encouraging material innovation are also enhancing local production capabilities, positioning the US as a major growth hub in the North American medical plastics landscape.

Market Players Outlook

The major companies operating in the North America medical plastics market include Celanese Corp., Dow Inc., Eastman Chemical Co., SABIC (Saudi Basic Industries Corp.), Solvay S.A., and others. The companies are pursuing partnerships, collaborations, mergers, and acquisitions to drive innovation, expand product portfolios, enhance sustainability, and strengthen market presence. These strategies enable players to respond to growing demand for energy-efficient, high-performance insulation solutions across residential, commercial, and industrial applications while maintaining a competitive edge.

Recent Developments

• In February 2025, Amcor finalized the acquisition of Berry Global’s health-and-nutrition unit for approximately $1.8 billion, aiming for leadership in consumer packaging for health, nutrition, and medical markets, and targeting $650 million in business synergies by 2028.

• In January 2025, West Pharmaceutical Services introduced Daikyo PLASCAP RUV closures in a new nested format, specifically for advanced therapies such as gene and viral treatments. These closures are made from metal-free polypropylene, supporting both sterility and compatibility with innovative drugs.

• In December 2024, TOPPAN Holdings agreed to purchase Sonoco’s thermoformed and flexible packaging business in North America for $1.8 billion, significantly expanding TOPPAN's presence in the regional medical packaging sector and adding $1.3 billion in annual revenue.

• In October 2024, Klöckner Pentaplast introduced kpNext MDR1, a fully recyclable medical device film that delivers traditional clarity and barrier performance with increased recyclability for the medical packaging sector.

The Report Covers

• Market value data analysis of 2024 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the North America medical plastics market. Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.